Health
COVID vaccines focus on the spike protein – but here’s another target – The Conversation UK
New research shows why the N protein might be a good target.
The latest results from the phase 3 COVID-19 vaccines trials have been very positive. These have shown that vaccinating people with the gene for SARS-CoV-2 spike protein can induce excellent protective immunity.
The spike protein is the focus of most COVID-19 vaccines as it is the part of the virus that enables it to enter our cells. Virus replication only happens inside cells, so blocking entry prevents more virus being made. If a person has antibodies that can recognise the spike protein, this…
-
General19 hours agoWhy the nation needs the Nationals to ditch Net Zero
-
General19 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News23 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
General19 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire